Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Val-Cit-PAB-Exatecan (TFA)

Val-Cit-PAB-Exatecan (Val-Cit-PAB-DX8951) TFA is a agent-linker conjugate for ADC. Val-Cit-PAB-Exatecan TFA is composed of a DNA topoisomerase I DX-8951 (HY-13631) and a cathepsin cleavable ADC linker[1].

Product Specifications

CAS Number

[2928571-44-0]

Product Name Alternative

Val-Cit-PAB-DX8951 (TFA)

UNSPSC

12352203

Target

Drug-Linker Conjugates for ADC; Topoisomerase

Type

ADC Related

Related Pathways

Antibody-drug Conjugate/ADC Related; Cell Cycle/DNA Damage

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/val-cit-pab-exatecan-tfa.html

Purity

99.73

Solubility

DMSO : 100 mg/mL (ultrasonic)

Smiles

CC(C)[C@H](N)C(N[C@@H](CCCNC(N)=O)C(NC(C=C1)=CC=C1COC(N[C@@H]2C3=C4C(C(N5C4)=CC([C@](O)(C(OC6)=O)CC)=C6C5=O)=NC7=CC(F)=C(C)C(CC2)=C73)=O)=O)=O.O=C(O)C(F)(F)F

Molecular Formula

C45H50F4N8O11

Molecular Weight

954.92

References & Citations

[1]Thomas A, et al. Antibody-drug conjugates for cancer therapy. Lancet Oncol. 2016 Jun;17 (6) :e254-e262.

Shipping Conditions

Blue Ice

Storage Conditions

-20°C (Powder, sealed storage, away from moisture)

Scientific Category

ADC Related

Clinical Information

No Development Reported

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Glibornuride-d7
TRC-G409702-100MG 100 mg

Glibornuride-d7

Ask
View Details
Kv3.4 Blocking Peptide
MBS823934-01 1 mg

Kv3.4 Blocking Peptide

Ask
View Details
Kv3.4 Blocking Peptide
MBS823934-02 5 mg

Kv3.4 Blocking Peptide

Ask
View Details
Kv3.4 Blocking Peptide
MBS823934-03 5x 5 mg

Kv3.4 Blocking Peptide

Ask
View Details
CD6 Antibody
V2961SAF-100UG 100 µg

CD6 Antibody

Ask
View Details
Incensole Acetate 2mg
A22402-2 2 mg

Incensole Acetate 2mg

Ask
View Details